References

[1] Hingrat QL, Visseaux B, Laouenan C, Tubiana S, Bouadma L, Yazdanpanah Y, et al. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives. Clin Microbiol Infect 2020. https://doi.org/10.1016/j.cmi.2020.11.025
[2] Shan D, Johnson JM, Fernandes SC, Suib H, Hwang S, Wuelfing D, et al. N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection. Nat Commun 2021; 12:1931. https://doi.org/10.1038/s41467-021-22072-9
[3] Sigal GB, Novak T, Mathew A, Chou J, Zhang Y, Manjula N, et al. Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay. Clin Infect Dis 2022; 75:1351-8. https://doi.org/10.1093/cid/ciac160
[4] Ogata AF, Maley AM, Wu C, Gilboa T, Norman M, Lazarovits R, et al. Ultra-Sensitive Serial Profiling of SARS-CoV-2 Antigens and Antibodies in Plasma to Understand Disease Progression in COVID-19 Patients with Severe Disease. Clin Chem 2020; 66:1562-72. https://doi.org/10.1093/clinchem/hvaa213
[5] Deng Q, Ye G, Pan Y, Xie W, Yang G, Li Z, et al. High Performance of SARS-Cov-2N Protein Antigen Chemiluminescence Immunoassay as Frontline Testing for Acute Phase COVID-19 Diagnosis: A Retrospective Cohort Study. Front Med (Lausanne) 2021; 8:676560. https://doi.org/10.3389/fmed.2021.676560
[6] Perna F, Bruzzaniti S, Piemonte E, Maddaloni V, Atripaldi L, Sale S, et al. Serum levels of SARS-CoV-2 nucleocapsid antigen associate with inflammatory status and disease severity in COVID-19 patients. Clin Immunol 2021; 226:108720. https://doi.org/10.1016/j.clim.2021.108720
[7] Verkerke HP, Damhorst GL, Graciaa DS, McLendon K, O’Sick W, Robichaux C, et al. Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection. J Infect Dis 2022. https://doi.org/10.1093/infdis/jiac225
[8] Yokoyama R, Kurano M, Nakano Y, Morita Y, Ohmiya H, Kishi Y, et al. Association of the Serum Levels of the Nucleocapsid Antigen of SARS-CoV-2 With the Diagnosis, Disease Severity, and Antibody Titers in Patients With COVID-19: A Retrospective Cross-Sectional Study. Front Microbiol 2021; 12:791489. https://doi.org/10.3389/fmicb.2021.791489
[9] Favresse J, Bayart JL, David C, Gillot C, Wieers G, Roussel G, et al. Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity. Viruses 2022; 14. https://doi.org/10.3390/v14081653
[10] Wick KD, Leligdowicz A, Willmore A, Carrillo SA, Ghale R, Jauregui A, et al. Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19. Crit Care 2022; 26:278. https://doi.org/10.1186/s13054-022-04153-3
[11] Zhang Y, Ong CM, Yun C, Mo W, Whitman JD, Lynch KL, et al. Diagnostic Value of Nucleocapsid Protein in Blood for SARS-CoV-2 Infection. Clin Chem 2021; 68:240-8. https://doi.org/10.1093/clinchem/hvab148
[12] Group A-TS, Rogers AJ, Wentworth D, Phillips A, Shaw-Saliba K, Dewar RL, et al. The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19. Ann Intern Med 2022; 175:1401-10. https://doi.org/10.7326/M22-0924
[13] Yilmaz A, Marklund E, Andersson M, Nilsson S, Andersson LM, Lindh M, et al. Upper Respiratory Tract Levels of Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Duration of Viral RNA Shedding Do Not Differ Between Patients With Mild and Severe/Critical Coronavirus Disease 2019. J Infect Dis 2021; 223:15-8. https://doi.org/10.1093/infdis/jiaa632